1. Home
  2. GTN vs EOLS Comparison

GTN vs EOLS Comparison

Compare GTN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GTN

Gray Television Inc.

HOLD

Current Price

$4.09

Market Cap

432.5M

Sector

Industrials

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.43

Market Cap

407.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTN
EOLS
Founded
1897
2012
Country
United States
United States
Employees
9582
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.5M
407.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
GTN
EOLS
Price
$4.09
$6.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$8.50
$15.50
AVG Volume (30 Days)
1.4M
945.8K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
5.79%
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$13.89
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
$11.72
N/A
Revenue Growth
N/A
11.61
52 Week Low
$3.50
$3.86
52 Week High
$6.44
$10.62

Technical Indicators

Market Signals
Indicator
GTN
EOLS
Relative Strength Index (RSI) 38.20 60.11
Support Level $3.85 $6.44
Resistance Level $5.10 $6.66
Average True Range (ATR) 0.20 0.28
MACD 0.00 -0.06
Stochastic Oscillator 41.32 58.28

Price Performance

Historical Comparison
GTN
EOLS

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: